Gold Nanocomposite Contact Lenses for Color Blindness Management.


Journal

ACS nano
ISSN: 1936-086X
Titre abrégé: ACS Nano
Pays: United States
ID NLM: 101313589

Informations de publication

Date de publication:
23 03 2021
Historique:
pubmed: 12 2 2021
medline: 15 5 2021
entrez: 11 2 2021
Statut: ppublish

Résumé

Color vision deficiency (CVD) is an ocular congenital disorder that affects 8% of males and 0.5% of females. The most prevalent form of color vision deficiency (color blindness) affects protans and deutans and is more commonly known as "red-green color blindness". Since there is no cure for this disorder, CVD patients opt for wearables that aid in enhancing their color perception. The most common wearable used by CVD patients is a form of tinted glass/lens. Those glasses filter out the problematic wavelengths (540-580 nm) for the red-green CVD patients using organic dyes. However, few studies have addressed the fabrication of contact lenses for color vision deficiency, and several problems related to their effectiveness and toxicity were reported. In this study, gold nanoparticles are integrated into contact lens material, thus forming nanocomposite contact lenses targeted for red-green CVD application. Three distinct sets of nanoparticles were characterized and incorporated with the hydrogel material of the lenses (pHEMA), and their resulting optical and material properties were assessed. The transmission spectra of the developed nanocomposite lenses were analogous to those of the commercial CVD wearables, and their water retention and wettability capabilities were superior to those in some of the commercially available contact lenses used for cosmetic/vision correction purposes. Hence, this work demonstrates the potential of gold nanocomposite lenses in CVD management and, more generally, color filtering applications.

Identifiants

pubmed: 33570901
doi: 10.1021/acsnano.0c09657
pmc: PMC8023801
doi:

Substances chimiques

Gold 7440-57-5

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

4870-4880

Références

ACS Nano. 2018 Jun 26;12(6):5130-5140
pubmed: 29688698
Occup Med (Lond). 1999 May;49(4):247-52
pubmed: 10474917
Adv Healthc Mater. 2018 Jun;7(12):e1800152
pubmed: 29696828
Curr Opin Biotechnol. 2000 Feb;11(1):54-61
pubmed: 10679342
Opt Express. 2018 Oct 29;26(22):28693-28703
pubmed: 30470042
Expert Opin Drug Deliv. 2009 Nov;6(11):1175-94
pubmed: 19743894
J Biomed Mater Res A. 2007 Nov;83(2):496-502
pubmed: 17503532
Cold Spring Harb Perspect Med. 2014 Aug 21;4(11):a017418
pubmed: 25147187
Am J Ophthalmol. 1961 Feb;51:298-305
pubmed: 13696552
Int Ophthalmol. 2019 Apr;39(4):797-801
pubmed: 29500697
Eye (Lond). 2010 May;24(5):747-55
pubmed: 19927164
Nature. 1999 Feb 11;397(6719):520-2
pubmed: 10028967
Eye (Lond). 2019 Dec;33(12):1877-1883
pubmed: 31270464
J Phys Condens Matter. 2017 May 24;29(20):203002
pubmed: 28426435
Aviat Space Environ Med. 2005 Feb;76(2):127-33
pubmed: 15742829
Qual Life Res. 2019 Apr;28(4):855-862
pubmed: 30443703
Optometry. 2007 Jan;78(1):17-22
pubmed: 17208670
Adv Drug Deliv Rev. 2008 Aug 17;60(11):1252-65
pubmed: 18558452
Nature. 2009 Oct 8;461(7265):784-7
pubmed: 19759534
Nano Rev. 2010;1:
pubmed: 22110855
Graefes Arch Clin Exp Ophthalmol. 2006 Apr;244(4):447-53
pubmed: 16133025
Ophthalmic Physiol Opt. 1997 Sep;17(5):403-8
pubmed: 9390366
Appl Opt. 1999 Nov 1;38(31):6581-6
pubmed: 18324193

Auteurs

Ahmed E Salih (AE)

Department of Mechanical Engineering, Khalifa University, Abu Dhabi, United Arab Emirates.

Mohamed Elsherif (M)

Department of Mechanical Engineering, Khalifa University, Abu Dhabi, United Arab Emirates.

Fahad Alam (F)

Department of Mechanical Engineering, Khalifa University, Abu Dhabi, United Arab Emirates.

Ali K Yetisen (AK)

Department of Chemical Engineering, Imperial College London, London SW7 2AZ, United Kingdom.

Haider Butt (H)

Department of Mechanical Engineering, Khalifa University, Abu Dhabi, United Arab Emirates.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH